glp 1 receptor agonists are contraindicated in Frontiers A Closer Look at the
Description
10.7150/thno.82920 120 YangC

These medications represent the direct pharmaceutical descendants of the original lizard venom discovery

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications
11 In clinical trials, exenatide has demonstrated efficacy in terms of both improved glycemic control and appetite suppression leading to weight loss

Additionally, there were more deaths in the Tirzepatide group than semaglutide (12 vs 1)

134979-01-4, CH2COOH-PEG2-NH2.HCl References: [1] Gribble FM, Reimann F
